Acute Lymphoblastic Leukemia Panel

Available viaHome Collection
GenderMale & Female
Contains24 parameters
Earliest reports inNext Day
PreparationNo preparation needed

Overview of Acute Lymphoblastic Leukemia Panel in Kottayam

The Acute Lymphoblastic Leukemia (ALL) Panel is a specialised flow cytometry (FCM) test used to identify and classify abnormal lymphoblasts in blood, bone marrow, or other appropriate samples. It analyses a combination of B-cell, T-cell, and other immunophenotypic markers to determine the type and subtype of acute lymphoblastic leukemia. This detailed immunophenotyping plays an important role in confirming the diagnosis, distinguishing ALL from other blood cancers, and providing information that helps guide treatment decisions.

Who Should Get This Test Done?

This test is recommended for:

●     Individuals with suspected acute lymphoblastic leukemia based on blood counts or bone marrow findings.

●     Individuals with symptoms such as persistent fever, unexplained fatigue, frequent infections, easy bruising, or bleeding.

●     Individuals with abnormal blast cells detected on a peripheral blood smear or bone marrow examination.

●     Individuals requiring immunophenotyping to classify the type of acute leukemia.

●     Individuals undergoing evaluation, staging, or follow-up of acute lymphoblastic leukemia as advised by their hematologist.

 Why Consider This Test?

  This test:

●     Helps confirm the diagnosis of acute lymphoblastic leukemia.

●     Differentiates between B-cell and T-cell lineage ALL.

●     Distinguishes ALL from other types of acute leukemia using immunophenotypic markers.

●     Provides valuable information that supports treatment planning and disease classification.

●     Offers high sensitivity for detecting abnormal blast cells through flow cytometry.

More Information

The Acute Lymphoblastic Leukemia Panel evaluates the expression of multiple B-lymphoid, T-lymphoid, myeloid, and non-lineage-specific markers using flow cytometry. Markers such as CD10, CD19, CD20, CD22, CD1a, CD2, CD3, CD7, CD34, HLA-DR, CD45, and CD33 help determine the immunophenotype of blast cells. The results are interpreted alongside clinical findings, blood counts, bone marrow examination, cytogenetic studies, and molecular tests to provide a comprehensive assessment of the disease.

Other Names

●     Acute Lymphoblastic Leukemia Immunophenotyping Panel

●     ALL Panel by Flow Cytometry

●     Acute Lymphoblastic Leukemia FCM Panel

●     Flow Cytometry for Acute Lymphoblastic Leukemia

●     ALL Immunophenotyping Test

Test included

Acute Lymphoblastic Leukemia Panel includes 24 parameters

  • Cd1a
  • Cd2
  • Cd3
  • Cd4
  • Cd5
  • Cd7
  • Cd8
  • Cd56

  • Cd10
  • Cd19
  • Cd10/cd19 (co-expression)
  • Cd20
  • Cd22
  • Smigm

  • Cd34
  • Hla Dr
  • Cd45

  • Instrument/software Used
  • Cell Preparation Method
  • Gating Strategy
  • Specimen Type
  • Wbc Count
  • Blast

  • Cd33

Test code

1606

CPT and Loinc codes

Department

  • Flow Cytometry

Turn around time

Next Day

Performing locations

4 labs across India

Specimen vol. and vacutainer information

SpecimenVacutainerVolume
Bone MarrowOthers11 ML
Edta Whole BloodLavender Vacutainer12 ML
Heparin Whole BloodGreen Vacutainer12 ML
Others (fx)Others10
SmearOthers20 NOS

Specimen stability information

Bone Marrow, Edta Whole Blood, Heparin Whole Blood, Smear

Collection instructions

2-3 unfixed, unstained direct smears + Detailed Clinical history medatory, Fluid send in RPMI 1:1 in plain container

Acute Lymphoblastic Leukemia Panel

₹12600

Health Checkup Category

Complete Care Packages

ACUTE LYMPHOBLASTIC LEUKEMIA PANEL Package in Other Cities

Need Assistance? Call 93334-93334 or Request a Callback from our health advisor!